DECODING THE HEALTHCARE
:
hat is the inspiration Eehind *enes 0e"
We realized that diagnostics and preventive healthcare in India are heavily reliant on blood tests to determine any underlying health condition, while the international markets enjoy a faster and more efficient diagnosis by testing genetics. So we established Genes2me Pvt. Ltd in 2016 to address the dire need of making testing more efficient. Currently, we are one of the leading NABL accredited Diagnostic labs in the Molecular Diagnostics space in India with a customer base of more than 5 million. We are happy that Genes2me has created a benchmark in the Diagnostics space by providing complete solutions not only under Routine Pathology testing but also in Advanced Molecular Diagnostics. Our vision is to deliver innovative and cost-effective genetic test solutions, and we are working tirelessly to achieve them. During first wave of COVID pandemic, Genes2me decided to step into manufacturing of IVD kits for COVID -19 and we are proud to say that till now we have manufactured & supplied more than 60 million testing kits till now and contributed in almost 1 in every 5 tests happened in India.
6ince 2micron is causing hayoc can you please taln aeout the nez 57 'irect 0ultiplex 573&5 Nit from *enes 0e and hoz it s Eringing a change in the &29,' testing"
Genes2me RT- Direct Multiplex RT-PCR kit for COVID-19 is based on the gold standard RT-PCR method with coverage of three target genes specific to SARS-COV-2 along with IC with extraction free fast protocol. It is much more advanced than all other kits having 1 or 2 target genes. This greatly increases the sensitivity of the RTPCR test to detect samples with different mutations/variants including Omnicron as this kit targets three different SARS-COV-2 target regions. Validated at the Indian Council of Medical Research (ICMR) approved center with 100 percent sensitivity and specificity, the newly launched kit can deliver results in just 40 minutes directly from VTM sample to PCR With this kit , testing capacity of a lab can be increased significantly without any change in existing infrastructure. With the surging cases of Omicron, the widely used RTPCR tests can be less effective as RT PCR Kits from Genes2me, having three SARS-COV-2 specific gene targets (Rdrp, E, and N gene), are much advance than other Kits with two gene targets as some studies indicates that a high number of mutations in SARS-COV-2 genome (~50 mutations in the case of Omicron) can lead to false-negative results and these can be reduced significantly by targeting more sequences within the viral genome.
6hed some light on your nez innoyatiye products testing solutions you are planning to Ering in the marnet and hoz you differentiate yourself from other existing players in the industry
Genes2me is already a trusted name in the field of genetic diagnostics and IVD industry in a very short period of time. We are majorly known for our international standard quality accredited products and services which are the need of the hour in diagnostics space across the world. Till now we have already manufactured and supplied more than 60 Million test kits in India and across the world, and are planning to scale up the manufacturing facility to develop next generation innovative IVD kits such as Next generation sequencing kits for different parameters, Molecular diagnostics kits, Rapid antigen tests kits etc. One of the innovative products which we have recently developed is world’s first Rapid RT-PCR Point of care solution Rapi-q HT which is a small compact Rapid RT PCR instrument which can detect the COVID Virus and many other infectious/ non-infectious parameters in just less than 30 minutes for 1 to 32 samples. We have also launched home testing kit Covieasy for COVID-19 testing at home which is integrated with a mobile application and has AI based reporting mechanism. These kits will be very soon available on many e-commerce websites and OTC platforms such as medical stores & pharmacies. These products has alredy received national and international accreditations and we are also working on filling patents for our few innovative new products.